Related Experiment Videos
Recent clinical trials in acute coronary syndromes without persistent ST elevation
1Duke University Medical Center, Durham, North Carolina 27710, USA. tolle004@onyx.dcri.duke.edu
Current Opinion in Cardiology
|September 29, 1999
Summary
Acute coronary syndromes (ACS) are serious heart conditions. Current treatments include aspirin, heparin, enoxaparin, and glycoprotein IIb/IIIa inhibitors, with ongoing research into optimal early intervention strategies.
Area of Science:
- Cardiology
- Internal Medicine
- Emergency Medicine
Background:
- Acute coronary occlusion, a critical aspect of coronary artery disease, results in substantial morbidity and mortality.
- Traditional classifications like Q-wave myocardial infarction are evolving towards acute coronary syndromes (ACS) with and without ST-segment elevation for better clinical guidance.
Purpose of the Study:
- To review the current understanding and management of acute coronary syndromes.
- To highlight evolving treatment strategies and the need for further clinical trials.
Main Methods:
- Review of current therapeutic agents including aspirin, heparin, enoxaparin, and glycoprotein IIb/IIIa inhibitors.
- Discussion of the ongoing debate regarding early intervention versus conservative management.
Main Results:
- Standard therapies have been augmented by newer agents like enoxaparin and glycoprotein IIb/IIIa inhibitors.
- The optimal timing and approach to intervention remain subjects of active clinical investigation.
Conclusions:
- Acute coronary syndromes require prompt and evolving treatment strategies.
- Continued clinical trials are essential to refine optimal management for this high-risk patient population.